PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

research reports and media, page-3422

  1. 1,704 Posts.
    lightbulb Created with Sketch. 1853
    That's the question i've been asking myself, because - someone correct me if i'm wrong - the FDA hasn't approved Bene's PPS in an injectible format before. Is that correct? This could be pretty encouraging for us, if so. I might have that wrong though.

    Regardless, i've not been able to find much at all about Anzac Animal Health (who, peculiarly, are not Aussie/NZ, but based in Missouri, US). Let alone get info on their API supplier for this drug.
    Last edited by Dungiven: 21/12/22
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
31.0¢
Change
0.035(12.7%)
Mkt cap ! $108.4M
Open High Low Value Volume
27.5¢ 31.0¢ 27.5¢ $108.9K 371.2K

Buyers (Bids)

No. Vol. Price($)
1 1000 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
31.0¢ 17420 5
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.